HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Boucheron

This article was originally published in The Rose Sheet

Executive Summary

Boucheron: Jaipur Homme "targeted" sampling program includes 5 mL edt sophistics, edt vials on card and scent seals, as well as a 15 mL edp replica for "special launch events," according to the company. The launch will also be supported with on-counter displays and a shelf glorifier, Boucheron noted. Targeted to 25- to 45-year-old men, Jaipur Homme was inspired by the gardens and architecture of the Indian city, according to the company. The juice, supplied by Firmenich, blends heliotrope flower, bergamot, amber and vanilla with a spicy "harmony" of cinnamon, clove, nutmeg and tonka bean. Available at Neiman Marcus in November, fragrance offerings range from $125 for a 100 mL edp spray to 1.7 oz. edt spray for $47. A 3.4 oz. aftershave is $46. The women's scent Jaipur de Boucheron bowed in 1994...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004776

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel